POXEL SA announced that Dr. Yohjiro Itoh has joined Poxel as Vice President Regulatory and Clinical Development Asia, effective April 7, 2015 to lead the company's drug development and registration efforts in Asia. Dr. Itoh brings Poxel over 30 years of life science industry experience with a focus on regulatory affairs. Dr. Itoh joins Poxel from CRO Mediscience Planning Inc. (MPI), where he served as Head of the Regulatory and Consulting Department.

Prior to MPI, he held key positions in both Regulatory Affairs and Clinical Research at Bayer Yakuhin, RPR Gencell, and some other Companies, during which he gained broad knowledge in into variety of fields including cardiovascular diseases, medical devices, oncology and immunology as well as gene therapy.